Facts & Figures

bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety.

What We Do

  • In , the Company offers a wide range of solutions mainly for managing infectious diseases.
  • For the agri-food, cosmetics and pharmaceutical industries, bioMérieux provides for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing.

Our Assets

  • A strong commitment and a long-term vision (family-owned company).
  • World leader in clinical microbiology.
  • Leader in industrial microbiological control for the agri-food, cosmetics and pharmaceutical industries.
  • Leader in the syndromic molecular diagnosis of infectious diseases.
  • A broad international footprint.

Key Figures

  • € 2.7 billion in sales (as of Dec. 31, 2019)
  • 2 main applications:
    • Clinical Diagnostics: ~ 83% of sales,
    • Industrial Microbiology: ~ 17% of sales.
  • 12,000 employees (full-time equivalents) at the end of December 2019.
  • Present 44 countries and serves more than 160 countries with the support of a large network of distributors;
    • Over 90% of international sales.
  • 18 production sites.
  • 18 R&D sites.
  • bioMérieux is listed on NYSE Euronext Paris.